Pharmacokinetic interactions between microemulsion formulated cyclosporine A and diltiazem in renal transplant recipients

European Journal of Clinical Pharmacology

Volumn 55, Issue 5, 1999, Pages 383-387

  Asberg A ^a,b   Christensen, H ^a   Hartmann, A ^a,b   Carlson, E ^a   Molden, E ^a   Berg, K J ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cyclosporin A; Diltiazem; Kidney transplantation

Indexed keywords

CYCLOSPORIN A; DILTIAZEM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MICROEMULSION; PRIORITY JOURNAL; SLOW RELEASE FORMULATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CYCLOSPORINE; DILTIAZEM; DRUG INTERACTIONS; EMULSIONS; ENZYME INHIBITORS; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0032876066     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050644     Document Type: Article

References (24)

1. Åsberg A, Christensen H, Hartmann A, Berg KJ (1998) Diltiazem modulates cyclosporine A induced renal hemodynamic effects but not its effect on plasma endothelin-1. Clin Transpl 12: 363-370
2. English J, Evan A, Houghton DC, Bennett WM (1987) Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 44: 135-141
3. Hansen JM, Fogh-Andersen N, Christensen NJ, Strandgaard S (1997) Cyclosporine-induced hypertension and decline in renal function in healthy volunteers. J Hypertens 15: 319-326
4. Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, Gasparini F, Remuzzi G (1992) Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 54: 56-60
5. Sturrock ND, Lang CC, Struthers AD (1994) Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans. J Hypertens 12: 919-924
6. Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G (1993) Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 43: 706-711
7. Sugihara J, Sugawara Y, Ando H, Harigaya S, Etoh A, Kohno K (1984) Studies on the metabolism of diltiazem in man. J Pharmacobiodyn 7: 24-32
8. Yabana H, Nagao T, Sato M (1985) Cardiovascular effects of the metabolites of diltiazem in dogs. J Cardiovasc Pharmacol 7: 152-157
9. Pichard L, Gillet G, Fabre I, Dalet-Beluche I, Bonfils C, Thenot JP, Maurel P (1990) Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab Dispos 18: 711-719
10. Kronbach T, Fischer V, Meyer UA (1988) Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 43: 630-635
11. Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA, Watkins PB (1994) Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test. Drug Metab Dispos 22: 947-955
12. Wagner K, Henkel M, Heinemeyer G, Neumayer HH (1988) Interaction of calcium blockers and cyclosporine. Transplant Proc 20: 561-568
13. Sabate I, Grino JM, Castelao AM, Huguet J, Seron D, Blanco A (1989) Cyclosporin-diltiazem interaction: Comparison of cyclosporin levels measured with two monoclonal antibodies. Transplant Proc 21: 1460-1461
14. Ferguson C, Wiliams J, Hillis A, Parry-Jones D, Salaman J (1992) Effects of the calcium channel blocker diltiazem on cyclosporine nephrotoxicity in renal transplant patients. Clin Transplantation 6: 391-398
15. Christensen H, Carlson E, Åsberg A, Schram L, Berg KJ (1999) A simple and sensitive HPLC assay of diltiazem and main metabolites in renal transplanted patients. Clin Chim Acta (in press)
16. Bergan S, Rugstad HE, Stokke O, Bentdal O, Froysaker T, Bergan A (1993) Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: A comparison between fluorescence polarization immunoassay and two different RIA methods. Scand J Clin Lab Invest 53: 471-477
17. Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300: 230-235
18. Jones TE, Morris RG, Mathew TH (1997) Diltiazem-cyclosporin pharmacokinetic interactio-dose-response relationship. Br J Clin Pharmacol 44: 499 504
19. Hsing S, Gatmaitan Z, Arias IM (1992) The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. Gastroenterology 102: 879-885
20. Emi Y, Tsunashima D, Ogawara K, Higaki K, Kimura T (1998) Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine. J Pharm Sci 87: 295-299
21. Yue QY, Sawe J (1997) Different effects of inhibitors on the O-and N-demethylation of codeine in human liver microsomes. Eur J Clin Pharmacol 52: 41 47
22. Kroemer HK, Eichelbaum M (1995) "It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism. Life Sci 56: 2285-2298
23. Kivisto KT, Kroemer HK (1997) Use of probe drugs as predictors of drug metabolism in humans. J Clin Pharmacol 37: 40S-48S
24. Alvan G, Bechtel P, Iselius L, Gundert-Remy U (1990) Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations. Eur J Clin Pharmacol 39: 533-537